Innovating Works

GRIT

Desconocido
VICT3R: Developing and implementing VIrtual Control groups To reducE animal use in toxicology Research VICT3R, a public-private partnership running under the European Innovative Health Initiative, aims to significantly reduce the number of ani...
2024-07-26 - 2028-02-29 | Financiado
ERA4TB: EUROPEAN REGIMEN ACCELERATOR FOR TUBERCULOSIS GRITSYSTEMS AS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The European Regimen Accelerator for Tuberculosis (ERA4TB) has the explicit goal of developing a new combination therapy to treat all forms...
2019-12-12 - 2025-12-31 | Financiado
COMBINE: Collaboration for Prevention and Treatment of MDR Bacterial Infections GRITSYSTEMS AS participó en un H2020: H2020-JTI-IMI2-2018-15-two-stage The loss of antibiotic effectiveness due to increasing antimicrobial resistance (AMR) is a serious threat to global public health. The IMI2...
2019-11-27 - 2025-10-31 | Financiado
TRANSLOCATION: Molecular basis of the outer membrane permeability GRITSYSTEMS AS participó en un FP6: Overcoming the barriers that the cell envelope and efflux pumps provide to Gram-negative bacteria is a major bottleneck in the discovery and...
2013-01-01 - 2018-06-30 | Financiado
TRANSLOCATION: Molecular basis of the outer membrane permeability GRITSYSTEMS AS participó en un FP7: Overcoming the barriers that the cell envelope and efflux pumps provide to Gram-negative bacteria is a major bottleneck in the discovery and...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.